Targeting P2X purinergic receptors with suramin alleviates rotenone-induced Parkinson's-like pathology via modulation of mitophagy and NLRP3-pyroptosis: Comparison with metformin
Fields of Study & Subjects
Adenosine and Purinergic Signaling
Parkinson's Disease Mechanisms and Treatments
Autophagy in Disease and Therapy
Publication details
- Journal / source
- Life Sciences
- Publisher
- Elsevier BV
- Volume
- 397
- Pages
- 124420–124420
- Publication date
- 1 May 2026
- Language
- EN